Actinogen Medical Limited logo

Actinogen Medical Limited

ASX:ACW.AX

Overview | Financials
Company Name Actinogen Medical Limited
Symbol ACW.AX
Currency AUD
Price 0.039
Market Cap 93,168,965
Dividend Yield 0%
52-week-range 0.015 - 0.099
Industry Biotechnology
Sector Healthcare
CEO Dr. Steven G. Gourlay ), FRACP, M.B.A., MBBS (M.D., Ph.D.
Website https://www.actinogen.com.au

An error occurred while fetching data.

About Actinogen Medical Limited

Actinogen Medical Limited, a biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia. It is developing Xanamem, an inhibitor of the 11ß-HSD1 enzyme, which is in Phase 2 clinical trials that achieves target engagement in the central nervous system, Alzheimer's disease, depression with

Related Stocks

Cyclopharm Limited logo

Cyclopharm Limited

CYC.AX

1.5 AUD

Ecofibre Limited logo

Ecofibre Limited

EOF.AX

0.025 AUD

SomnoMed Limited logo

SomnoMed Limited

SOM.AX

0.425 AUD

Recce Pharmaceuticals Ltd logo

Recce Pharmaceuticals Ltd

RCE.AX

0.545 AUD

EMVision Medical Devices Ltd logo

EMVision Medical Devices Ltd

EMV.AX

2.1 AUD

Oneview Healthcare PLC logo

Oneview Healthcare PLC

ONE.AX

0.335 AUD

Cann Group Limited logo

Cann Group Limited

CAN.AX

0.037 AUD

Prescient Therapeutics Limited logo

Prescient Therapeutics Limited

PTX.AX

0.045 AUD

Kazia Therapeutics Limited logo

Kazia Therapeutics Limited

KZA.AX

0.08 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD